Search research articles
Contact Us
Filters
Showing results (71-80 of 113) with videos related to
Page
of 12
Sort By:
The Journal of Clinical Investigation
|
April 1, 2026
Androgen receptor splice variant 7 expression levels distinguish AR-mutated from nonmutated metastatic castration-resistant prostate cancers
Alec Paschalis, Ines Figueiredo, Denisa Bogdan, et al.
Oncogene
|
September 12, 2024
AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer
Sumaira Sardar, Christopher M McNair, Lakshmi Ravindranath, et al.
European Urology Oncology
|
March 12, 2026
An Open-label, Phase 1 Dose-finding Study of Single-agent IMU-935, a Novel RORγ/RORγt Inverse Agonist, in Patients with Progressive Metastatic Castration-resistant Prostate Cancer
Rafael Grochot, Christina Guo, Suzanne Carreira, et al.
Nature Medicine
|
June 27, 2025
Defactinib with avutometinib in patients with solid tumors: the phase 1 FRAME trial
Susana Banerjee, Matthew G Krebs, Alastair Greystoke, et al.
Investigational New Drugs
|
May 15, 2026
A Phase I trial of the anti-IL23 monoclonal antibody tildrakizumab, in combination with abiraterone acetate, for the treatment of metastatic castration-resistant prostate cancer
Khobe Chandran, Christina Guo, Simon Pacey, et al.
Cell Reports
|
January 19, 2018
BRD4 Promotes DNA Repair and Mediates the Formation of TMPRSS2-ERG Gene Rearrangements in Prostate Cancer
Xiangyi Li, GuemHee Baek, Susmita G Ramanand, et al.
European Urology
|
September 4, 2017
Novel Junction-specific and Quantifiable In Situ Detection of AR-V7 and its Clinical Correlates in Metastatic Castration-resistant Prostate Cancer
Yezi Zhu, Adam Sharp, Courtney M Anderson, et al.
Oncogene
|
May 3, 2019
Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer
Claire E Fletcher, Eric Sulpice, Stephanie Combe, et al.
Nature
|
June 29, 2018
IL-23 secreted by myeloid cells drives castration-resistant prostate cancer
Arianna Calcinotto, Clarissa Spataro, Elena Zagato, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 29, 2020
Characterizing CDK12-Mutated Prostate Cancers
Pasquale Rescigno, Bora Gurel, Rita Pereira, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 113) with videos related to
Sort By:
Page
of 12
The Journal of Clinical Investigation
|
April 1, 2026
Androgen receptor splice variant 7 expression levels distinguish AR-mutated from nonmutated metastatic castration-resistant prostate cancers
Alec Paschalis, Ines Figueiredo, Denisa Bogdan, et al.
Oncogene
|
September 12, 2024
AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer
Sumaira Sardar, Christopher M McNair, Lakshmi Ravindranath, et al.
European Urology Oncology
|
March 12, 2026
An Open-label, Phase 1 Dose-finding Study of Single-agent IMU-935, a Novel RORγ/RORγt Inverse Agonist, in Patients with Progressive Metastatic Castration-resistant Prostate Cancer
Rafael Grochot, Christina Guo, Suzanne Carreira, et al.
Nature Medicine
|
June 27, 2025
Defactinib with avutometinib in patients with solid tumors: the phase 1 FRAME trial
Susana Banerjee, Matthew G Krebs, Alastair Greystoke, et al.
Investigational New Drugs
|
May 15, 2026
A Phase I trial of the anti-IL23 monoclonal antibody tildrakizumab, in combination with abiraterone acetate, for the treatment of metastatic castration-resistant prostate cancer
Khobe Chandran, Christina Guo, Simon Pacey, et al.
Cell Reports
|
January 19, 2018
BRD4 Promotes DNA Repair and Mediates the Formation of TMPRSS2-ERG Gene Rearrangements in Prostate Cancer
Xiangyi Li, GuemHee Baek, Susmita G Ramanand, et al.
European Urology
|
September 4, 2017
Novel Junction-specific and Quantifiable In Situ Detection of AR-V7 and its Clinical Correlates in Metastatic Castration-resistant Prostate Cancer
Yezi Zhu, Adam Sharp, Courtney M Anderson, et al.
Oncogene
|
May 3, 2019
Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer
Claire E Fletcher, Eric Sulpice, Stephanie Combe, et al.
Nature
|
June 29, 2018
IL-23 secreted by myeloid cells drives castration-resistant prostate cancer
Arianna Calcinotto, Clarissa Spataro, Elena Zagato, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 29, 2020
Characterizing CDK12-Mutated Prostate Cancers
Pasquale Rescigno, Bora Gurel, Rita Pereira, et al.
Page
of 12